The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Ameren's revenues will drop -9.5% and EPS will wane -32.9%.
The average estimate for revenue is $1.50 billion. On the bottom line, the average EPS estimate is $0.49.
Last quarter, Ameren booked revenue of $1.48 billion. GAAP reported sales were 3.9% higher than the prior-year quarter's $1.37 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.22. GAAP EPS were -$0.60 for Q1 versus -$1.66 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 33.9%, 190 basis points better than the prior-year quarter. Operating margin was 13.0%, 140 basis points better than the prior-year quarter. Net margin was -10.2%, much better than the prior-year quarter.
The full year's average estimate for revenue is $6.35 billion. The average EPS estimate is $2.10.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 190 members out of 232 rating the stock outperform, and 42 members rating it underperform. Among 67 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 58 give Ameren a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Ameren is hold, with an average price target of $33.80.
Looking for alternatives to Ameren? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Ameren to My Watchlist.